Barroilhet evaluates endometrial cancer data in Targeted Oncology

Lisa Barroilhet, MD, MS, director of the Division of Gynecologic Oncology, discussed trials that may be of interest for patients with recurrent endometrial cancer with Targeted Oncology during a Case-Based Roundtable event. 

In the discussion, Barroilhet reviewed data from a few recent trials for patients with recurrent endometrial cancer. She shared patient characteristics in some of the trials, frequency of adverse events, and a case study for a patient with recurrent cancer who participated in one of the trials.  

Read the whole conversation here